|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
| ||||||||||||||||||||
Files in this Data Supplement:
Table S1. Integrin antibodies used in this study.
Fig. S1. Adhesion and spreading of normal endoderm cells on ECM substrates. Endoderm cells were isolated from 5-day normal EBs and cultured on fibronectin (Fn), laminin-111 (Lm), type IV collagen (Col IV) or vitronectin (Vn) for 16 hours. The cells were immunostained for integrin β1 and paxillin. Nuclei were counterstained with DAPI.
Fig. S2. Effect of MAPK and PI3K-Akt inhibition on the spreading of integrin-β1-null endoderm cells on vitronectin. Integrin-β1-null endoderm cells were cultured on vitronectin and treated with various kinase inhibitors for 2 days. The cells were stained for integrin β3 and nuclei were counterstained with DAPI. The MEK1/2 inhibitor U0126 slightly inhibited cell spreading.
Fig. S3. Expression of constitutively active H-Ras in integrin-β1-null endoderm cells induces GATA4 nuclear translocation and cellular maturation. (a) Integrin-β1-null endoderm cells were transfected with the pCXN2-RasV12-IRES-GFP vector encoding a CA H-Ras or the empty vector. The transfected cells were stained for GATA4 and Dab2. (b) The cells were also analyzed by western blotting for laminin-111, nidogen and Dab2.
| ||||||||||||||||||||